Bär & Karrer advises Miele o the Establishment of a Joint Venture in the Fields of Infection Control and Life Science Miele and Metall Zug have reached an agreement outlining the establishment of a
Search Results for: lenz & staehelin
In a groundbreaking move, the City of Geneva revealed its venture into the green bonds arena, successfully raising an impressive CHF 140 million in aggregate principal amount. This marks the City’s inaugural foray into green
In a strategic move to advance innovation in the Infection Control and Life Science domain, Metall Zug and Miele have inked a transformative agreement. The deal outlines the creation of a new joint venture, where
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
Starrag and Tornos, the two traditional Swiss precision machine tool manufacturers, both listed at the SIX Swiss Exchange, announced on October 26, 2023 that they entered into a merger agreement. Under the terms of the merger, Tornos
Mablink Bioscience, a pre-clinical company pioneering the development of next-generation antibody-drug conjugates via its PSARLinkTM proprietary platform, announced an agreement to be acquired by Eli Lilly and Company. The biotechnology company is developing the next
Nadia Ohlhoff-Smahi has been appointed Vice-President of the AIJA International Arbitration Commission with effect from 25 August 2023. Nadia is a senior associate in the Geneva office of Lenz & Staehelin, where she practices in the areas
On October 4, 2023, Novartis successfully executed the spin-off of Sandoz by distributing Sandoz shares as a dividend-in-kind to Novartis shareholders and American Depositary Receipts (ADRs) holders. Sandoz shares are now listed on the SIX Swiss Exchange.